N/A
N=39
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
Pregestational Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT06141941 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Number of Participants With Hypoglycemia During Postpartum Hospital Stay — 5; 2; 4; 5 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CGM (Device)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Iowa
- Primary completion
- Apr 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Hypoglycemia During Postpartum Hospital Stay |
5; 2; 4; 5 | — |
Summary
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Eligibility Criteria
Inclusion:
1- Individuals in the third trimester of pregnancy admitted to the hospital with diabetes type 1 or diabetes type 2, own a smart device (which will serve as a receiver for the CGM device)
Exclusion:
- Patients less than 18 years of age
- non-English speaking patients
- gestational diabetes
- extensive skin changes/diseases that inhibit wearing a sensor on normal skin, known allergy to adhesives
Data sourced from ClinicalTrials.gov (NCT06141941). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.